Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06199986 · ClinicalTrials.gov registry record · NA
DeADT - Living Well With Prostate Cancer
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06199986 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 50 participants.
The verdict
NCT06199986, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this randomized de-implementation trial is to compare two strategies to reduce low-value androgen deprivation therapy (ADT) use for prostate cancer care. The aim of the study is to compare implementation of the two strategies: use of a clinical reminder order check intervention versus a provider script/patient education approach, and their impacts on low-value ADT use after six months. The main goal of both interventions will be to decrease ADT overuse for patients with prostate cancer, but to do this in a way that is acceptable to the clinicians who treat these patients. The interventions will be initiated for providers only across 4 participating facilities. Provider participants will engage with one of the interventions triggered in the electronic health record when their patients are deemed likely to be receiving low-value ADT. Each provider participant receives only one of the interventions. The intervention is triggered for every clinic visit involving a patient deemed to be receiving low-value ADT, so provider participants may receive their assigned intervention multiple times. Researchers will compare provider use of both strategies to determine implementation outcomes and whether one was more effective in reducing low-value ADT use.
Interventions
- BEHAVIORAL ADT Order Check Attestation (Or)
- BEHAVIORAL Provider Script (Sc)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2024-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06199986
The ClinicalTrials.gov registry entry for NCT06199986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ADT Order Check Attestation (Or) is the first listed.
NCT06199986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06199986 about?
NCT06199986 is a clinical study titled "DeADT - Living Well With Prostate Cancer". The goal of this randomized de-implementation trial is to compare two strategies to reduce low-value androgen deprivation therapy (ADT) use for prostate cancer care. The aim of the study is to compare implementation of the two strategies: use of a clinical reminder order check intervention versus a ...
What is the current status of trial NCT06199986?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-10-04. Estimated completion is 2024-04-16.
What interventions are being tested in trial NCT06199986?
The interventions under investigation include: ADT Order Check Attestation (Or) (BEHAVIORAL), Provider Script (Sc) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06199986?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.